Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Yuko OKUBO"'
Autor:
Akira Shimizu, Kyoichi Kaira, Yuko Okubo, Daisuke Utsumi, Masahito Yasuda, Takayuki Asao, Masahiko Nishiyama, Kenzo Takahashi, Osamu Ishikawa
Publikováno v:
Journal of Global Oncology, Vol 3, Iss 4, Pp 360-369 (2017)
Purpose: Programmed death-1 (PD-1) or programmed death ligand-1 (PD-L1) targeted therapies have shown promising survival outcomes in several human neoplasms. However, it is unclear whether the expression of PD-L1 can be correlated to any clinical and
Externí odkaz:
https://doaj.org/article/cda11e5a45b04bd99177d7bd37f56996
Autor:
Nobuyuki Maruyama, Yuko Okubo, Masato Umikawa, Akiko Matsuzaki, Akira Hokama, Fusahiro Hirano, Tessho Maruyama, Kazuhide Nishihara, Toshiyuki Nakasone, Shoko Makishi, Hiroyuki Nakamura, Naoki Yoshimi
Publikováno v:
Diagnostics, Vol 10, Iss 4, p 218 (2020)
Currently, Kaposi’s sarcoma (KS) is treated following the recommendations of international guidelines. These guidelines recommend esophagogastroduodenoscopy/colonoscopy for detecting multicentric KS of visceral lesions. Second primary malignancies
Externí odkaz:
https://doaj.org/article/006a744994b049a2910ac884862fd639
Autor:
Yuka Okamoto, Kenzo Takahashi, Hitoshi Kawada, Ryo Yasumura, Sayaka Yamaguchi, Takuya Miyagi, Yuko Okubo
Publikováno v:
The Journal of Dermatology
Pyrethroid insecticides are the only pesticides approved for the treatment of head lice (pediculosis capitis) infestations in Japan. However, in Okinawa Prefecture, 96% of head lice are resistant to pyrethroids. Here, we conducted a clinical trial to
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 82:2107-2112
Autor:
Koji Tanaka, Yuko Okubo, Hiroyuki Nakashizuka, Hiroyuki Shimada, Ryusaburo Mori, Takayuki Hattori
Publikováno v:
Japanese Journal of Ophthalmology. 63:396-401
In our previous report, intravitreal injection using 0.25% povidone-iodine to irrigate the conjunctival sac together with pre- and post-injection topical antibiotics achieved an incidence of post-injection endophthalmitis significantly lower than oth
Autor:
Natsuko Yamakawa, Kiyoto Kurima, Akira Arasaki, Zensei Toyoda, Yasuka Tanabe, Shinichiro Kina, Hirofumi Arakawa, Kenzo Takahashi, Takao Kinjo, Haruna Ishikawa, Sayaka Yamaguchi, Masayuki Tsuneki, Daisuke Utsumi, Yuko Okubo, Karina Uehara, Ayumi Tamanaha-Nakasone
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Kaposi’s sarcoma-associated herpesvirus (KSHV) causes both AIDS-related Kaposi’s sarcoma (KS) and classic KS, but their clinical presentations are different, and respective mechanisms remain to be elucidated. The KSHV K1 gene is reportedly involv
Autor:
Naoki Yoshimi, Yuko Okubo, Tessho Maruyama, Hiroyuki Nakamura, Toshiyuki Nakasone, Fusahiro Hirano, Kazuhide Nishihara, Akiko Matsuzaki, Akira Hokama, Masato Umikawa, Nobuyuki Maruyama, Shoko Makishi
Publikováno v:
Diagnostics
Diagnostics, Vol 10, Iss 218, p 218 (2020)
Diagnostics, Vol 10, Iss 218, p 218 (2020)
Currently, Kaposi’s sarcoma (KS) is treated following the recommendations of international guidelines. These guidelines recommend esophagogastroduodenoscopy/colonoscopy for detecting multicentric KS of visceral lesions. Second primary malignancies
Autor:
Hiroyuki Nakashizuka, Ari Shinojima, Yumiko Machida, Hiroyuki Shimada, Mitsuko Yuzawa, Takayuki Hattori, Yuko Okubo, Yu Wakatsuki
Publikováno v:
Canadian Journal of Ophthalmology. 52:398-402
Objective This study aimed to evaluate the usefulness of a new wet laboratory (wet lab) system using porcine eyes with eyelids. Design Teaching device trial. Participants Porcine eyes with orbital tissues and eyelids. Methods Twenty porcine eyes with
Autor:
Daisuke Utsumi, Kyoichi Kaira, Masahiko Nishiyama, Yuko Okubo, Kenzo Takahashi, Masahito Yasuda, Takayuki Asao, Osamu Ishikawa, Akira Shimizu
Publikováno v:
Journal of Global Oncology
Journal of Global Oncology, Vol 3, Iss 4, Pp 360-369 (2017)
Journal of Global Oncology, Vol 3, Iss 4, Pp 360-369 (2017)
Purpose Programmed death-1 (PD-1) or programmed death ligand-1 (PD-L1) targeted therapies have shown promising survival outcomes in several human neoplasms. However, it is unclear whether the expression of PD-L1 can be correlated to any clinical and